SonoSite to Present at Two Investor Conferences In September -- Northwest Medical Device & Biotechnology Forum and UBS Global Li
September 14 2005 - 4:43PM
Business Wire
SonoSite, Inc. (Nasdaq:SONO), the world leader in hand-carried
ultrasound, today announced that Mike Schuh, Chief Financial
Officer, and Anne Bugge, Vice President of Corporate Affairs, will
present at the Northwest Medical Device & Biotechnology
Investor Forum at 10:00 a.m. (ET) on Tuesday, September 20, 2005,
at the Harvard Club of New York City. The forum is hosted by
Delafield Hambrecht and WBBA. SonoSite also announced that Kevin M.
Goodwin, President and CEO, will present at the 2005 UBS Global
Life Sciences Conference at 12:30 p.m. (ET) on Wednesday, September
28 at the Grand Hyatt Hotel in New York City. Investors can access
an audio-webcast of Mr. Goodwin's presentation on SonoSite's
website http://www.sonosite.com/webcast.html. The webcast will be
available beginning September 28, 2005, until 3:30 p.m. (ET)
October 29, 2005. About SonoSite SonoSite, Inc. (www.sonosite.com)
is the innovator and world leader in hand-carried ultrasound, with
an installed base of more than 20,000 systems. The company,
headquartered near Seattle, Washington, is represented by seven
subsidiaries and a global distribution network in over 75
countries. Approximately half of the company's revenues are
generated from international markets. SonoSite's small, lightweight
systems are expanding the use of ultrasound across the clinical
spectrum by cost-effectively bringing high performance ultrasound
to the point of patient care. The company employs approximately 450
people worldwide.
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sonos (NASDAQ:SONO)
Historical Stock Chart
From Jul 2023 to Jul 2024